New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
08:33 EDTTEVATeva announces FDA grants SYNRIBO full approval
Teva Pharmaceutical announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO for injection. This oncology portfolio product received an accelerated approval in October 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA. The company said, "With this approval, based on the final analysis of two Phase II trials that evaluated efficacy and tolerability data of SYNRIBO, we believe healthcare providers can be even more confident in the clinical profile of this important medicine."
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use